We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
+12.83%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$3.27B
AUM Growth
+$170M
Cap. Flow
-$151M
Cap. Flow %
-4.62%
Top 10 Hldgs %
19.26%
Holding
132
New
3
Increased
35
Reduced
93
Closed
1

Top Buys

Rank Stock Value
1
NOG icon
Northern Oil and Gas
NOG
+$12.9M
2
LKQ icon
LKQ Corp
LKQ
+$5.23M
3
MODV
ModivCare
MODV
+$3.07M
4
CRNC icon
Cerence
CRNC
+$2.05M
5
ROG icon
Rogers Corp
ROG
+$1.62M

Sector Composition

Rank Sector Weight
1 Industrials 25.41%
2 Technology 18.57%
3 Healthcare 16%
4 Financials 13.89%
5 Consumer Discretionary 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VBTX
76
DELISTED
Veritex Holdings
VBTX
$18.4M 0.56%
792,429
+9,035
+1% +$178K
PTEN icon
77
Patterson-UTI
PTEN
$3.82B
$18.4M 0.56%
1,705,310
-869,076
-34% -$10.6M
HLF icon
78
Herbalife
HLF
$1.33B
$17.9M 0.55%
1,173,596
+10,019
+0.9% +$138K
CSL icon
79
Carlisle Companies
CSL
$15B
$17.5M 0.54%
56,160
-7,643
-12% -$2.1M
IWN icon
80
iShares Russell 2000 Value ETF
IWN
$14.6B
$17.1M 0.52%
109,869
-2,700
-2% -$374K
CHCT
81
Community Healthcare Trust
CHCT
$514M
$16.6M 0.51%
621,304
+13,204
+2% +$364K
DBI icon
82
Designer Brands
DBI
$340M
$16.3M 0.5%
1,842,695
-18,191
-1% -$191K
RRC icon
83
Range Resources
RRC
$9.23B
$16M 0.49%
524,264
-77,146
-13% -$2.53M
AHRT
84
AH Realty Trust
AHRT
$542M
$15.9M 0.49%
1,289,043
+3,815
+0.3% +$42.1K
NUS icon
85
Nu Skin
NUS
$255M
$15.5M 0.47%
799,168
+20,399
+3% +$376K
ATNI icon
86
ATN International
ATNI
$380M
$15.1M 0.46%
386,413
+23,064
+6% +$762K
INFN
87
DELISTED
Infinera Corporation Common Stock
INFN
$14.9M 0.46%
3,144,245
-6,184
-0.2% -$24.3K
FANG icon
88
Diamondback Energy
FANG
$54B
$14.1M 0.43%
91,042
-12,573
-12% -$1.97M
LQDT icon
89
Liquidity Services
LQDT
$1.22B
$14.1M 0.43%
820,378
+27,102
+3% +$516K
JBGS
90
JBG SMITH
JBGS
$679M
$13.9M 0.42%
815,312
-46,376
-5% -$675K
CNS icon
91
Cohen & Steers
CNS
$4.38B
$13.7M 0.42%
181,357
-27,799
-13% -$1.67M
NDAQ icon
92
Nasdaq
NDAQ
$52.4B
$13.7M 0.42%
235,553
-30,194
-11% -$1.59M
ATR icon
93
AptarGroup
ATR
$8.69B
$13.3M 0.41%
107,674
-14,082
-12% -$1.77M
ROG icon
94
Rogers Corp
ROG
$2.35B
$13M 0.4%
98,600
+12,679
+15% +$1.62M
TITN icon
95
Titan Machinery
TITN
$447M
$13M 0.4%
449,360
+22,835
+5% +$592K
INSW icon
96
International Seaways
INSW
$4.6B
$12.8M 0.39%
281,275
+8,829
+3% +$406K
NOG icon
97
Northern Oil and Gas
NOG
$2.22B
$12.6M 0.39%
+339,979
New +$12.9M
WWW icon
98
Wolverine World Wide
WWW
$1.61B
$12.1M 0.37%
1,363,678
+54,531
+4% +$464K
EHC icon
99
Encompass Health
EHC
$10.9B
$12M 0.37%
179,797
-22,729
-11% -$1.47M
FFIC
100
DELISTED
Flushing Financial
FFIC
$11.9M 0.37%
725,111
+19,775
+3% +$276K

Similar funds

Aristotle Capital Boston's Q4 2023 Portfolio in Review

As of Q4 2023, Aristotle Capital Boston held 132 positions worth $3.27B, up 5.5% from $3.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Aristotle Capital Boston withdrew a net $151M in Q4 2023, closing 1 position and reducing 93 holdings. Its most notable exit was Coherus Oncology, an estimated $8.76M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Aristotle Capital Boston opened a new position in Northern Oil and Gas worth $12.6M.

  • Aristotle Capital Boston's largest Q4 2023 buy was Northern Oil and Gas: 339,979 shares worth $12.6M.
  • Aristotle Capital Boston added most to ModivCare in Q4 2023, an estimated $3.07M increase.
  • Aristotle Capital Boston's biggest Q4 2023 reduction was SP Plus Corporation, cutting an estimated $20.9M.
  • Aristotle Capital Boston fully exited Coherus Oncology in Q4 2023, selling an estimated $8.76M.
  • Aristotle Capital Boston's ten largest holdings make up 19% of its $3.27B portfolio in Q4 2023.
  • Aristotle Capital Boston opened 3 new positions and closed 1 in Q4 2023.
  • Aristotle Capital Boston's portfolio value rose 5.5% quarter-over-quarter to $3.27B.

Based on Aristotle Capital Boston's 13F filing for Q4 2023, filed 14 Feb 2024.